Accel-Amplicon NGS Panels utilize multiple overlapping amplicons in a single tube, using a rapid, 2-hour workflow to prepare ready-to-sequence libraries. Primer pairs in Accel-Amplicon NGS Panels are compatible with short DNA fragments and are designed for generating libraries from input DNA as low as 10 ng.
Swift Summer Webinar Series
SWIFT NORMALASE™ AMPLICON 16S & ITS1 PANELS (SNAP)
and the 16S SNAP APP for Data Analysis
Thursday, July 9th at 12:00 EST
In 2019, Swift Biosciences launched their 16S+ITS Accel-Amplicon panel to enable highly efficient, sensitive, and specific microbial identification through targeting the 16S rRNA (V1-V9) and ITS genes in a single primer pool. Now Swift has launched 16S SNAP and ITS SNAP, which combine the sensitivity […]
Swift Summer Webinar Series
Featuring Swift 2S™ Turbo
Thursday, June 11th at 12:00 EST
The increasing scale of next-generation sequencers necessitates rapid and automatable workflows for high-throughput library preparation. Swift’s 2S™ Turbo utilizes a highly reproducible means of enzymatic fragmentation for consistent insert size regardless of input quantity or sample GC content. Validated using Swift’s Exome hybridization capture panel, a mock microbial community, and whole genome sequencing of […]
ANN ARBOR, Mich. – May 28, 2020 — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift’s assay enables research and surveillance activities by accommodating the low viral copy titers found in clinical specimens. The […]
ANN ARBOR, Mich. June 3, 2020 /PRNewswire/ — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology within the Swift RNA Library Kits combined with myBaits technology from Arbor Biosciences for hybridization-based target enrichment of […]
Tuesday, June 16th at 8:00 am EDT
SIGN UP HERE!
The emergence of SARS-CoV-2 has resulted in the need for NGS strategies for characterizing the viral genome. Sequencing of the full-length genome is critical for identifying mutational variants and contributing to research in the fields of virology, immunology, epidemiology, and molecular evolution, among others. However, maximizing viral RNA sequencing reads from clinical specimens can be challenging, particularly due to […]
The Accel-NGS Adaptase Module constructs NGS libraries from bisulfite-converted DNA from single cells. The Adaptase Module maximizes the recovery of low concentrations of single stranded DNA and libraries consistently exhibit superior complexity with reduced composition bias to provide a more faithful representation of the methylome. Using the in-line barcoding option, cells can be mulitplexed to increase throughput and further reduce library prep costs.
Swift SARS-CoV-2 Amplicon Panel: NGS in a SNAP
Register to receive a recording of the Swift SARS-CoV-2 Amplicon Panel: NGS in a SNAP webinar
Recorded Wednesday, June 3rd at 12:00 pm EST
SIGN UP HERE!
The emergence of SARS-CoV-2 has resulted in the need for NGS strategies for characterizing the viral genome. Sequencing of the full-length genome is critical for identifying mutational variants and contributing to research […]
ANN ARBOR, Mich., May 5, 2020 /PRNewswire/ — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), announced the release of its Swift Amplicon SARS-CoV-2 Research Panel. Targeting the full viral genome in a single reaction with a rapid 2-hour workflow, Swift’s assay meets research and surveillance needs for standard samples by converting and enriching viral cDNA into NGS-ready libraries. As a […]
Register to receive a recording of the Swift Biosciences and Arbor Biosciences webinar
Recorded Wednesday, May 13, 12:00 pm EST
SIGN UP HERE!
The emergence of COVID-19 has resulted in the need for NGS strategies for characterizing the SARS-CoV-2 viral genome. Sequencing of the full-length genome is critical for identifying mutational variants and contributing to research in the fields of virology, immunology, […]
Recording of the webinar for VarSome Clinical, organized jointly with Swift Biosciences. Swift Biosciences is a biotechnology company that is developing novel molecular biology technologies to better characterize and understand the genome. We are an energetic, highly innovative company focused on creating tools to advance the DNA sequencing sciences. Our products are designed to help customers analyze challenging samples that are often associated with translational work, including circulating, cell-free DNA and formalin-fixed, […]
(ANN ARBOR, Mich. – February 24, 2020) Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), today announced a partnership agreement with LGC, Biosearch Technologies, a global leader in specialty genomic analysis tools to leverage Swift’s targeted sequencing technology into LGC Biosearch Techologies kits and service offerings for the worldwide AgBio market.
Under this arrangement, LGC will be Swift’s exclusive worldwide partner for amplicon-based targeted […]
(ANN ARBOR, Mich. – February 4, 2020) Swift Biosciences, Inc (“Swift”) and Helix OpCo, LLC (“Helix”) today announced a Partnership Agreement to leverage Swift’s 2S Turbo DNA library preparation for Helix’s Exome+™ assay. Helix, a population genomics company, uses the Exome+™ assay to power population health programs focused on accelerating the integration of genomics into clinical care and facilitating novel genetic discovery.
Swift 2S™ Turbo launched in the summer of 2018 and was Swift’s […]
Swift Biosciences and Opentrons Partner to Provide a Turnkey Automated NGS Library Preparation Workflow
(ANN ARBOR, Mich. – January 27, 2020) Swift Biosciences, Inc (“Swift”) and Opentrons Labworks, Inc. (“Opentrons”) today at the SLAS2020 conference announce their partnership to leverage Swift’s efficient NGS library preparation kits on Opentrons’ open-source automation platform.
This partnership launches pre-scripted automation protocols for preparing DNA libraries using Swift 2S™ Turbo DNA Library Kits on Opentrons’ OT-2 liquid handler with the goal to expand into RNA and targeted sequencing workflows.
Swift 2S Turbo provides reproducible […]
(ANN ARBOR, Mich. – January 14, 2020) Swift Biosciences, Inc. (“Swift”), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift’s DNA and RNA library preparation products in Europe and Asia Pacific markets.
With this agreement, Swift and MGI will work to enable Swift’s library preparation […]
Swift Biosciences, Inc. Welcomes Steven Riedmuller to its Executive Team
(Ann Arbor, MI October 15, 2019) Swift Biosciences, Inc, a leader in library preparation for Next-Generation Sequencing announces the addition of Steven Riedmuller to its leadership team, as Director of Field Application Services. Steven is uniquely suited to spearhead the FAS division with his experience and leadership at Maxygen, Synthetic Genomics, Hudson Robotics and TIGR. While at Synthetic Genomics, Hudson Robotic and TIGR Steve […]